Evidence map›Paper›PMID 41041065›Full record

ArticleTheranostics2025

ASIC1a Induces Excessive Mitophagy and PANoptosis of Chondrocyte by the Inhibition of SIRT3 Mitochondrial Translocation.

Zhuoyan Zai, Xuewen Qian, Yayun Xu, Huifang Lv, Mengjia Hao, Yueming Tao, Lixin Rui, Xiaoyue Zhang, Xiaoqing Peng, Yihao Zhang and 1 more

Abstract read
In one paragraph

Article in Theranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Targeting the non-coding RNA-PANoptosis axis: a novel frontier in disease diagnosis and therapy.Apoptosis : an international journal on programmed cell death · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhuoyan ZaiSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.
Xuewen QianSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.
Yayun XuDepartment of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen 518035, China.
Huifang LvSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.
Mengjia HaoSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.
Yueming TaoSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.
Lixin RuiDepartment of Medicine., University of Wisconsin School of Medicine and Public Health, Madison 53705, WI, USA.
Xiaoyue ZhangSchool of Public Health, Anhui Medical University, Hefei 230032, China.
Xiaoqing PengSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.
Yihao ZhangSchool of Public Health, Anhui Medical University, Hefei 230032, China.
Feihu ChenSchool of Pharmacy, Anhui Medical University, Hefei 230032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acid Sensing Ion ChannelsArthritis, RheumatoidChondrocytesMitochondriaMitophagySirtuin 3AnimalsArthritis, ExperimentalCartilage, ArticularCells, CulturedFemaleHumansMaleRatsRats, Sprague-DawleySirtuinsAcid Sensing Ion ChannelsAsic1 protein, ratSIRT3 protein, ratSirtuin 3SirtuinsASIC1amitophagyoxidative stressPANoptosisSIRT3

Identifiers

PMID41041065
PMCPMC12486255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.